Form 8-K - Current report:
SEC Accession No. 0001641172-25-002130
Filing Date
2025-04-01
Accepted
2025-04-01 17:15:18
Documents
14
Period of Report
2025-03-26
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44466
  Complete submission text file 0001641172-25-002130.txt   270242

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bblg-20250326.xsd EX-101.SCH 3805
3 XBRL DEFINITION FILE bblg-20250326_def.xml EX-101.DEF 30068
4 XBRL LABEL FILE bblg-20250326_lab.xml EX-101.LAB 36757
5 XBRL PRESENTATION FILE bblg-20250326_pre.xml EX-101.PRE 27091
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5891
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40899 | Film No.: 25800866
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
(CF Office: 08 Industrial Applications and Services)